Tumor mutational burden as a potential biomarker for PD1/PD-L1 therapy in colorectal cancer.
Authors:
- 20 May 2016
- journal article
- abstracts
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (15_suppl) , 3587